- Search results for A0A291I686
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "A0A291I686"!
Close filters
Filter by:
No results were found for the filter!
COVID-19 Research
Item number: BPS-100757-1
Middle East Respiratory Syndrome Coronavirus 3C-like protease (MERS-CoV 3CL Protease), GenBank Accession No. ATG84821.1, a.a. 1-306(full length), with an N-terminal MBP-tag, and C-terminal His-tag, expressed in an E. coli expression system, MW=78 kDa.
Keywords: | ORF1a, |
Application: | Enzyme kinetics, inhibitor screening, selectivity profiling |
Expressed in: | E.coli |
Origin: | mers-cov |
MW: | 78 kD |
From 521.00€
*
Item number: BPS-78278
The 3CL Protease (MERS-CoV) Inhibitor Screening Assay Kit is designed to measure 3CL Protease activity for screening and profiling applications, in a homogeneous assay with no time-consuming washing steps. A protease inhibitor cocktail is included as a positive control. Assay Principle: 3CL Protease (MERS-CoV) Assay...
Keywords: | nsp5, p65 homolog, Leader protein, 3C-like proteinase, Papain-like proteinase, Non-structural protein 7, Non-structural... |
Application: | Enzyme kinetics, drug discovery, HTS |
Species reactivity: | MERS-CoV |
1,997.00€
*